Orleans Capital Management Corp Pfizer Inc Transaction History

Orleans Capital Management Corp

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$27.03 - $38.62 $2.02 Million - $2.89 Million	-74,771 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$32.92 - $37.36 $18,106 - $20,548	-550 Reduced 0.73%	74,771 $2.93 Million
Q3 2019 Nov 15, 2019	SELL	$32.49 - $42.13 $172,197 - $223,289	-5,300 Reduced 6.57%	75,321 $2.71 Million
Q2 2019 Aug 15, 2019	SELL	$36.98 - $41.52 $431,593 - $484,579	-11,671 Reduced 12.65%	80,621 $3.49 Million
Q1 2019 May 15, 2019	SELL	$37.5 - $41.2 $213,375 - $234,428	-5,690 Reduced 5.81%	92,292 $3.92 Million
Q4 2018 Feb 15, 2019	SELL	$38.47 - $43.86 $67,322 - $76,755	-1,750 Reduced 1.75%	97,982 $4.28 Million
Q3 2018 Nov 15, 2018	BUY	$34.47 - $41.81 $34,470 - $41,810	1,000 Added 1.01%	99,732 $4.4 Million
Q2 2018 Aug 20, 2018	SELL	$32.98 - $35.16 $34,629 - $36,918	-1,050 Reduced 1.05%	98,732 $3.58 Million
Q1 2018 May 15, 2018	SELL	$31.91 - $37.02 $65,351 - $75,816	-2,048 Reduced 2.01%	99,782 $3.54 Million
Q4 2017 Feb 09, 2018	SELL	$33.26 - $35.29 $23,282 - $24,703	-700 Reduced 0.68%	101,830 $3.69 Million
Q3 2017 Nov 20, 2017	BUY	$31.0 - $34.15 $3.18 Million - $3.5 Million	102,530	102,530 $3.66 Million

3,253

3.72B

73.5M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $154B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Orleans Capital Management Corp, based on Form 13F filings with the SEC.

Stay updated on Orleans Capital Management Corp with notifications on news.